Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 24, 2021	Sep. 25, 2020
Cash Flows From Operating Activities:
Net loss	$ (513.4)
Adjustments to reconcile net cash from operating activities:
Depreciation and amortization	506.1	$ 675.5
Share-based compensation	8.4	17.6
Deferred income taxes	(19.1)	304.0
Non-cash impairment charges	64.5	63.5
Losses (gains) on divestiture	0.8	(10.1)
Reorganization Items, non-cash	22.5	0.0
Other non-cash items	(6.0)	(21.6)
Changes in assets and liabilities:
Accounts receivable, net	105.7	61.1
Inventories	(30.9)	(43.9)
Accounts payable	14.7	(52.4)
Income taxes	92.5	(431.2)
Opioid-related litigation settlement liability	125.0	0.0
Medicaid lawsuit	(4.8)	640.2
Other	40.4	(116.3)
Net Cash From Operating Activities	406.4	294.7
Cash Flows From Investing Activities:
Capital expenditures	(39.2)	(42.4)
Proceeds from divestitures, net of cash	15.7	(0.7)
Other	(1.4)	(6.7)
Net Cash From Investing Activities	(22.1)	(36.4)
Cash Flows From Financing Activities:
Repayment of external debt	(128.2)	(134.6)
Debt financing costs	0.0	(9.3)
Repurchase of shares	0.0	(0.4)
Other	0.0	(36.3)
Net Cash Provided From Financing Activities	(128.2)	(180.6)
Effect of currency rate changes on cash	(0.9)	0.2
Net change in cash, cash equivalents and restricted cash	255.2	77.9
Cash, cash equivalents and restricted cash at beginning of period	1,127.0	822.6
Cash, cash equivalents and restricted cash at end of period	1,382.2	900.5
Cash and cash equivalents, end of period	1,322.6	844.2
Restricted Cash and Investments, Current	23.3	20.2
Restricted Cash and Investments, Noncurrent	36.3	36.1
Retained Earnings (Deficit)
Cash Flows From Operating Activities:
Net loss	$ (513.4)	$ (791.7)